Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DELPHIA
NCT03467152Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2018
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of Irsenontrine in dementia with Lewy bodies (DLB), sponsored by Eisai Co., Ltd.. Started May 2018; status: completed.
02
Drugs
Irsenontrine
03
Conditions
dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on NCT03467152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03467152.